Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

831 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
Takahashi S, Narita S, Fujiyama N, Hatakeyama S, Kobayashi T, Kato R, Naito S, Sakatani T, Kashima S, Koizumi A, Yamamoto R, Nara T, Kanda S, Numakura K, Saito M, Obara W, Tsuchiya N, Ohyama C, Ogawa O, Habuchi T. Takahashi S, et al. Among authors: koizumi a. Cancer Sci. 2022 Dec;113(12):4059-4069. doi: 10.1111/cas.15488. Epub 2022 Sep 24. Cancer Sci. 2022. PMID: 35848083 Free PMC article.
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.
Narita S, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Koizumi A, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nomura K, Habuchi T. Narita S, et al. Among authors: koizumi a. Int J Clin Oncol. 2020 May;25(5):912-920. doi: 10.1007/s10147-019-01614-8. Epub 2020 Jan 9. Int J Clin Oncol. 2020. PMID: 31919691
A patient with synchronous bilateral low-grade upper tract urothelial carcinoma who underwent nephroureterectomy and total ureterectomy with ileal ureteric replacement.
Matsuda Y, Inoue T, Maeno A, Koizumi A, Yamamoto R, Nara T, Kanda S, Numakura K, Saito M, Narita S, Satoh S, Habuchi T. Matsuda Y, et al. Among authors: koizumi a. Int Cancer Conf J. 2020 Mar 3;9(2):82-87. doi: 10.1007/s13691-020-00402-w. eCollection 2020 Apr. Int Cancer Conf J. 2020. PMID: 32257759 Free PMC article.
Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer.
Matsuda Y, Narita S, Nara T, Mingguo H, Sato H, Koizumi A, Kanda S, Numakura K, Saito M, Inoue T, Hiroshima Y, Nanjo H, Satoh S, Tsuchiya N, Habuchi T. Matsuda Y, et al. Among authors: koizumi a. BMC Cancer. 2020 Apr 15;20(1):302. doi: 10.1186/s12885-020-06844-y. BMC Cancer. 2020. PMID: 32293349 Free PMC article.
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes.
Numakura K, Kobayashi M, Hatakeyama S, Naito S, Horikawa Y, Tanaka T, Kamada S, Muto Y, Yamamoto R, Koizumi A, Nara T, Kanda S, Saito M, Narita S, Inoue T, Shimoda N, Tsuchiya N, Ohyama C, Habuchi T. Numakura K, et al. Among authors: koizumi a. Int J Clin Oncol. 2020 Aug;25(8):1543-1550. doi: 10.1007/s10147-020-01693-y. Epub 2020 May 11. Int J Clin Oncol. 2020. PMID: 32394047
Prognostic value of plasminogen activator inhibitor-1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib.
Honma N, Inoue T, Tsuchiya N, Koizumi A, Yamamoto R, Nara T, Kanda S, Huang M, Numakura K, Saito M, Narita S, Satoh S, Habuchi T. Honma N, et al. Among authors: koizumi a. Health Sci Rep. 2020 Oct 15;3(4):e197. doi: 10.1002/hsr2.197. eCollection 2020 Dec. Health Sci Rep. 2020. PMID: 33088925 Free PMC article.
831 results